Maestro Rechargeable System

Ranar 14 ga watan Janairu, 2015, Cibiyar Abinci da Drugura ta Amirka (FDA) ta amince da na'urar likita ta farko don kula da kiba. Wannan na'urar, wanda aka sani da Maestro Rechargeable System, an yarda don amfani a wasu tsofaffi masu girma. Wannan ita ce na'urar farko na likita da za a yarda da ita ta FDA don kula da kiba tun 2007.

Idan aka ba haka, bisa ga Cibiyoyin Kula da Cututtuka da Cututtuka (CDC), kashi ɗaya cikin uku na dukan manya na Amurka sunyi girma, zuwan sabon likita don maganin shi ne labarai da ke ba da hankali sosai.

Ta yaya Yayi aiki?

Maestro Rechargeable System yana aiki ne ta hanyar ƙaddamar da hanzarin ƙwayar cuta tsakanin kwakwalwa da ciki wanda ke sarrafa iko akan jin yunwa da cikakke. Ya ƙunshi gilasar wutar lantarki wanda yake karɓa, tare da tasirin waya da zaɓuɓɓuka. Wadannan an dasa su cikin jiki. Bayan haka yana aika motsin wutar lantarki ga nervous naman, wanda ke taimakawa wajen sarrafa ciki da kuma aika sakonni ga kwakwalwa cewa ciki yana da komai ko cikakke.

A cewar kamfanin EnteroMedics Inc., kamfanin da ke sa na'urar, Maestro Rechargeable System blocks ya nuna cewa cutar naman za a aika zuwa kwakwalwa, don haka ya rage jin yunwa da kuma sa marasa lafiya su ji dadi a baya.

Wanene Ana Bukata?

Bisa ga FDA, an yarda da wannan na'urar likita don balagagge (shekarun 18 da haihuwa) waɗanda suke da alamun jikin mutum (BMI) daga 35 zuwa 45, tare da akalla yanayin kiwon lafiya mai mahimmanci, irin su ciwon sukari 2 ko haɗari barci na barci .FDA ta kayyade cewa wadannan marasa lafiya sun nuna cewa sun kasa samun nauyi ta hanyar shirin hasara.

Yaya Yayi Amfani?

A cikin gwaji na gwaji wanda ya shafi marasa lafiya da BMI na 35 ko mafi girma, waɗanda ke cikin ƙungiyar gwaji (waɗanda suka karbi Maestro mai aiki) sun ga sakamakon rashin nauyi-hasara: kimanin rabi daga cikinsu sun rasa akalla kashi 20 cikin nauyin nauyin nauyin, kuma 38% daga cikinsu sun rasa akalla 25% na nauyin nauyin da suka wuce.

Mene ne Hanyoyin Kasuwanci?

Sakamakon sakamakon da aka ruwaito a cikin gwaji na asibiti inda aka amince da su sun hada da: raunuka, vomiting, ciwo a wurin gine-gine, ƙwaƙwalwar ƙwayar cuta, ƙwaƙwalwar ƙwayar zuciya, zafi ciwo, wahalar haɗari, da kuma belching. Kamar yadda yake tare da kowane aiki ko hanya, akwai rikitarwa, kamar kamuwa da cuta da zub da jini, wanda ya haifar da hanya ta kanta.

FDA ta lura cewa, a matsayin wani ɓangare na amincewar, EnteroMedics dole ne gudanar da binciken shekaru biyar wanda ya biyo bayan akalla 100 marasa lafiya na tsawon shekaru biyar kuma ya tattara ƙarin bayani game da aminci da tasiri na na'urar.

Abinci da Daidaitaccen Daidaici Duk da haka Ana Bukata

Babu shakka wannan na'urar bata kawar da buƙata don ci gaba da kulawa da abincin abinci mara kyau a cikin abincin da aka sarrafa da kuma yawan 'ya'yan itatuwa da kayan marmari. Kuma ba ya kawar da mahimmanci na bukatar kasancewar aiki a yau .

Dukkanin wadannan matakan kiwon lafiyar suna da muhimmanci ba kawai ga asarar nauyi ba, amma don hana dukkan cututtukan cututtuka, ciki har da cututtukan zuciya, bugun jini, ciwon sukari, ciwon daji, da nakasa.

Sources :

FDA. Rahotanni: FDA ta amince da kayan aikin farko don magance kiba. Samun shiga yanar gizo a http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm430223.htm ranar 16 ga Janairu, 2015.